Every peptide on the market.

Osteoanabolic treatment of osteoporosis in patients at high fracture risk.

Investigational GH-fragment analog studied for potential fat-modulating and anti-obesity effects.

Topical cosmetic peptide studied for reducing the appearance of facial expression lines.

Investigational cytoprotective peptide studied for tissue repair and vascular/gastrointestinal protection.

A synthetic pentadecapeptide investigated for its pleiotropic cytoprotective, pro-angiogenic, and regenerative effects across multiple organ systems.

Cagrilintide is a long-acting amylin analog investigated for the treatment of obesity and type 2 diabetes through central appetite regulation.

A neuropeptide complex used to promote neurorecovery and neuroprotection in acute ischemic stroke, traumatic brain injury, and neurodegenerative disorders.

CJC-1295 is a long-acting synthetic GHRH analog designed to stimulate endogenous growth hormone and IGF-1 secretion via pituitary GHRH receptor activation.

A bovine-derived polypeptide complex used primarily in Russia as a neurotropic agent for neuroprotection, cognitive impairment, and developmental delay.

Degarelix is a GnRH receptor antagonist used as androgen-deprivation therapy to treat advanced hormone-dependent prostate cancer by suppressing testosterone.

Desmopressin is a synthetic V2-selective vasopressin analog used to treat central diabetes insipidus and manage mild hemophilia A and von Willebrand disease.

A synthetic, brain-penetrant Angiotensin IV analog and IRAP inhibitor studied for its potential procognitive and neuroprotective effects.

An endogenous nonapeptide primarily studied for its ability to induce delta (slow-wave) sleep and its potential neuroprotective and cardioprotective effects.

Dulaglutide is a once-weekly GLP-1 receptor agonist used to improve glycemic control and reduce cardiovascular risk in adults with type 2 diabetes.

A synthetic tetrapeptide analogue of epithalamin studied for its potential to activate telomerase, modulate gene expression, and extend cellular lifespan.

Exenatide is a GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes mellitus.

A synthetic senolytic peptide designed to selectively eliminate senescent cells by disrupting the FOXO4-p53 complex and triggering p53-dependent apoptosis.

GHK-Cu is a tripeptide-copper complex used primarily in cosmetic and regenerative medicine to improve skin quality, wound healing, and tissue remodeling.

Topical GHK-Cu is a copper-binding tripeptide used in cosmeceuticals for skin rejuvenation, wound repair, and antioxidant gene modulation.

GHRP-2 is a synthetic hexapeptide ghrelin mimetic used primarily as a diagnostic agent to stimulate and assess growth hormone secretory function.

GHRP-6 is a synthetic growth hormone secretagogue and ghrelin mimetic used primarily in research to stimulate GH release and study organ protection.

A synthetic decapeptide used as a diagnostic tool for HPG axis assessment and as a pulsatile therapy for congenital hypogonadotropic hypogonadism.

A GnRH agonist used to suppress pituitary gonadotropins and gonadal steroids for treating hormone-sensitive cancers and gynecological conditions.

Hexarelin is a synthetic growth hormone secretagogue used as a research tool to study GH release, cardioprotection, and lipid metabolism.

Humanin is a mitochondrial-derived peptide investigated for its neuroprotective, cytoprotective, and metabolic regulatory effects in age-related diseases.

Icatibant is a selective bradykinin B2 receptor antagonist used for the on-demand treatment of acute attacks of hereditary angioedema.

Ipamorelin is a synthetic pentapeptide and selective ghrelin receptor agonist used to stimulate growth hormone release and study GHSR1a signaling.

A decapeptide agonist of the KISS1 receptor used to regulate reproductive hormones and investigate anti-metastatic and anti-senescence pathways.

KPV is an experimental C-terminal tripeptide of alpha-MSH studied for its anti-inflammatory effects in mucosal tissues and inflammatory bowel disease models.

Lanreotide is a somatostatin analog used to treat acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) by inhibiting hormone secretion and tumor growth.

Larazotide acetate is an investigational synthetic octapeptide tight-junction regulator designed to antagonize zonulin and restore intestinal barrier function.

A synthetic GnRH agonist used to suppress sex steroid production in hormone-sensitive conditions like prostate cancer and central precocious puberty.

Linaclotide is a guanylate cyclase-C agonist used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).

Liraglutide is a long-acting GLP-1 receptor agonist used to improve glycemic control in type 2 diabetes and manage chronic weight in obesity.

Lixisenatide is a short-acting GLP-1 receptor agonist used to improve glycemic control, specifically postprandial glucose, in adults with type 2 diabetes.

LL-37 is a human cathelicidin host-defense peptide studied for its broad-spectrum antimicrobial, immunomodulatory, and wound-healing properties.

A synthetic lipopeptide used in cosmeceuticals to stimulate collagen production and reduce the appearance of skin aging.

Mazdutide is a long-acting GLP-1R and GCGR dual agonist investigated for the treatment of obesity, type 2 diabetes, and metabolic disorders.

A synthetic alpha-MSH analogue used to increase eumelanin production and prevent phototoxicity in patients with erythropoietic protoporphyria.

A synthetic cyclic melanocortin receptor agonist used as a research tool to study pigmentation, sexual function, and stress responses.

MK-677 is an orally active ghrelin mimetic and growth hormone secretagogue studied for reversing catabolism and increasing lean mass in older adults.

A 16-amino acid mitochondrial-derived peptide that regulates metabolic homeostasis, stress resistance, and mitochondrial biogenesis via the AMPK pathway.

N-Acetyl Selank is an experimental, modified analog of the Russian peptide Selank, studied for potential anxiolytic, nootropic, and immunomodulatory effects.

N-Acetyl Semax is a synthetic ACTH-like peptide derivative studied for neuroprotection, nootropic effects, and modulation of neurotrophic factors.

A synthetic somatostatin analog used to inhibit growth hormone and treat symptoms of functional neuroendocrine tumors.

Oxytocin is a nonapeptide hormone used clinically for labor induction, augmentation, and the management of postpartum hemorrhage.

P21 is a synthetic tetrapeptide mimetic of CNTF studied for its neurogenic, neurotrophic, and synaptic repair effects in neurodegenerative models.

Pentadeca arginate is a synthetic analog of BPC-157 investigated for cytoprotection, wound healing, and multi-organ repair via nitric oxide modulation.

Plecanatide is a guanylate cyclase-C agonist used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.

Pramlintide is a synthetic amylin analog used as an adjunct to mealtime insulin to improve glycemic control in adults with type 1 and type 2 diabetes.

Bremelanotide is a melanocortin receptor agonist used for the on-demand treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.

Retatrutide is an investigational triple hormone receptor agonist (GLP-1, GIP, and glucagon) studied for obesity, type 2 diabetes, and liver disease.

Selank is a synthetic heptapeptide nootropic and anxiolytic used to treat anxiety spectrum disorders and enhance cognitive function under stress.

A long-acting GLP-1 receptor agonist used for glycemic control in Type 2 Diabetes and chronic weight management in obesity.

A synthetic ACTH(4-7) analog used as a nootropic and neuroprotective agent, primarily studied for acute ischemic stroke and cognitive enhancement.

Sermorelin is a synthetic GHRH analog used for the diagnostic evaluation of growth hormone deficiency and the stimulation of endogenous GH secretion.

SNAP-8 is a synthetic octapeptide used in topical cosmetic formulations to reduce facial expression lines by inhibiting neurotransmitter release.

A mitochondria-targeted tetrapeptide that binds cardiolipin to stabilize the inner membrane, reduce oxidative stress, and improve bioenergetics.

Survodutide is an investigational GLP-1 and glucagon receptor dual agonist studied for weight loss, glycemic control, and metabolic dysfunction-associated steatohepatitis.

A synthetic fragment of Thymosin Beta-4 studied for its potential to promote tissue repair, angiogenesis, and cell migration in various injury models.

A synthetic N-terminal fragment of thymosin beta-4 studied for its putative regenerative and actin-sequestering properties in tissue repair.

Teriparatide is a recombinant human parathyroid hormone (1-34) used as an anabolic therapy to increase bone mass and reduce fracture risk in severe osteoporosis.

A growth hormone-releasing hormone (GHRH) analog used to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy.

Thymalin is a thymic peptide complex used as an immunomodulator to restore T-cell function and regulate cytokine production in immunodeficiency and inflammation.

Thymogen is a synthetic Glu-Trp dipeptide used as an immunomodulatory and hemostimulatory agent to normalize immune function and hematopoietic recovery.

An endogenous 28-amino-acid peptide used as an immunomodulatory adjuvant for chronic viral infections, certain cancers, and immunodeficiency states.

A dual GIP and GLP-1 receptor agonist used for glycemic control in type 2 diabetes and chronic weight management in obesity.

An endogenous neuropeptide and immunomodulator studied for its roles in vasodilation, smooth muscle relaxation, and suppression of inflammatory responses.

Ziconotide is a synthetic non-opioid peptide used for the intrathecal management of severe chronic pain refractory to other treatments.